Why the study?
Does angiotensin II perfusion attenuate the hypotensive action of captopril in normotensive and spontaneously hypertensive rats?
Does angiotensin II perfusion attenuate the hypotensive action of captopril in normotensive and spontaneously hypertensive rats?
The suppression of plasma angiotensin II explains a minor part of the acute hypotensive effect of captopril in normotensive rats, but a major part of its action in spontaneously hypertensive rats.
Suggests greater reliance on angiotensin suppression for captopril in hypertensive versus normotensive models; hypothesis-generating and should not yet change practice.
The effect of intravenous (i.v.) captopril on mean arterial blood pressure (MABP) of anaesthetized normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats perfused i.v. with two doses of angiotensin II (ANG II; 2.9 and 5.8 pmol/kg per min) was studied to determine the role of the suppression of plasma ANG II in the hypotensive action of captopril. The reduction of MABP by captopril was attenuated in WKY and abolished in SHR by the highest dose of ANG II; it was unchanged in WKY and attenuated in SHR by the lowest dose of ANG II. The suppression of plasma ANG II thus explains a minor part of the acute reduction of MABP by captopril in WKY and a major part of this action in SHR. Plasma ANG II contributes to the maintenance of high blood pressure in SHR.
No takes yet. Share an insight, caveat, or question.
Staroukine et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: